Predicting the development of schizophrenia in high-risk populations: Systematic review of the predictive validity of prodromal criteria

British Journal of Psychiatry

Volumn 199, Issue 5, 2011, Pages 361-366

  Chuma, Jefter ^a   Mahadun, Prem ^a  

^a GREATER MANCHESTER MENTAL HEALTH NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL ASSESSMENT TOOL; CLINICAL TRIAL; DISEASE COURSE; EVIDENCE BASED PRACTICE; HIGH RISK POPULATION; HUMAN; PREDICTION; PREDICTIVE VALIDITY; PRODROMAL CRITERIA; REVIEW; SCHIZOPHRENIA; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SUSCEPTIBILITY; EPIDEMIOLOGIC STUDIES; FALSE POSITIVE REACTIONS; HUMANS; PREDICTIVE VALUE OF TESTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; STATISTICS AS TOPIC; TIME FACTORS;

EID: 80655134669     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.110.086868     Document Type: Review

References (51)

1. Knowles L, Sharma T. Identifying vulnerability markers in prodromal patients: a step in the right direction. CNS Spectrums 2004; 9: 594-602.
2. Yung AR, Phillips LJ, Yuen HP, McGorry PD, Ward J, Donovan K, et al. Comprehensive Assessment of at Risk Mental States (CAARMS), January 2002. PACE Clinic, Department of Psychiatry, University of Melbourne, 2002.
3. Miller TJ, McGlashan TH, Rosen JL, Cadenhead K, Ventura J, McFarlane W, et al. Prodromal assessment with structured interview for prodromal syndromes and scale of prodromal symptoms: predictive validity, interrater reliability and training to reliability. Schizophr Bull 2003; 29: 703-15. (Pubitemid 38181951)
4. Phillips LJ, Yung AR, McGorry PD. Identification of young people at risk of psychosis: validation of personal assessment and crisis evaluation intake criteria. Aust N Z J Psychiatry 2000; 34: 164-9.
5. Olsen KA, Rosenbaum B. Prospective investigations of prodromal state of schizophrenia: assessment instruments. Acta Psychiatr Scand 2006; 113: 273-82.
6. Gross G, Huber G, Klosterkotter J. Bonn Scale for the Assessment of Basic Symptoms - BSABS. Springer, 1987.
7. McGlashan TH, Miller TJ, Woods SW, Rosen JL,Hoffman RE, Davidson L. Structured Interview for Prodromal Syndromes (Version 4.0). Yale School of Medicine, 2003.
8. Marshall M, Lewis S, Lockwood A. Association between duration of untreated psychosis and outcome in cohorts of first episode patients: a systematic review. Arch Gen Psychiatry 2005; 62: 975-83. (Pubitemid 41248376)
9. Perkins D, Gu H, Boteva K. Rationship between duration of untreated psychosis and outcome in first episode schizophrenia: a critical review and meta-analysis. Am J Psychiatry 2005; 162: 1785-804. (Pubitemid 41428609)
10. McGlashan TH, Addington J, Cannon T, Heinimaa M, McGorry P, O'Brien M, et al. Recruitment and treatment practices for help seeking prodromal patients. Schizophr Bull 2007; 33: 1-2.
11. Haroun N, Dunn L, Haroun A, Cadenhead KS. Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research. Schizophr Bull 2006; 32: 166-78. (Pubitemid 43063832)
12. Warner R. Problems with early and very early intervention in psychosis. Br J Psychiatry 2005; 187: s104-7. (Pubitemid 41139674)
13. Ruhrmann S, Schultze-Luther F, Klosterkotter J. Probably at-risk, but certainly ill - advocating the introduction of a psychosis spectrum disorder in DSM-V. Schizophr Res 2010; 120: 23-37.
14. Schardt C, Adams MB, Owens T, Keitz S, Fontelo P. Utilization of the PICO framework to improve searching PubMed for clinical questions. BMC Med Inform Decis Mak 2007; 7: 16.
15. Deville WL, Bunxix F, Bouter LM, Montori VM, De Vet HC, Van Der DA, et al. Conducting systematic reviews of diagnostic studies: diadactic guidelines. BMC Meds Res Methodol 2003; 2: 9.
16. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). APA, 1994.
17. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. The STARD Statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med 2003; 138: w1-12.
18. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003; 3: 25.
19. NHS Centre for Reviews and Dissemination. Undertaking Systematic Reviews of Research on Effectiveness: CRD's Guidance for those Carrying out or commissioning Reviews. NHS Centre for Reviews and Dissemination, University of York, 2001.
20. Sackett DL, Haynes RB. Evidence base of clinical diagnosis: the architecture of diagnostic research. BMJ 2002; 324: 539-41. (Pubitemid 34185274)
21. Zamora J, Abraira V, Muriel A, Khan KS, Coomarasamy A. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 2006; 6: 31.
22. Walter SD. Properties of the summary receiver-operating characteristic (sROC) curve for diagnostic test data. Stat Med 2002; 21: 1237-56. (Pubitemid 34467232)
23. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60. (Pubitemid 37088507)
24. Klosterkötter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry 2001; 58: 158-64. (Pubitemid 32142753)
25. Yung AR, Phillips LJ, Yuen HP, Francey SM, McFarlane CA, Hallgren M, et al. Pychosis prediction: 12 months follow up of at risk (prodromal) group. Schizophr Res 2003; 60: 21-32.
26. Yung AR, Phillips LJ, Yuen HP, McGorry PD. Risks factors for psychosis in an ultra-high risk group: psychological and clinical features. Schizophr Res 2004; 67: 131-42. (Pubitemid 38251443)
27. Mason O, Startup M, Halpin S, Schall U, Conrad A, Carr V. Risk factors for transition for first episode psychosis among individuals with 'at-risk mental states'. Schizophr Res 2004; 71: 2-3.
28. Yung AR, Phillips LJ, Yuen HP, McGorry PD, Kelly D, Dell'olio M, et al. Mapping the onset of psychosis: the comprehensive assessment of at risk mental states. Aust N Z J Psychiatry 2005; 39: 964-71. (Pubitemid 43904432)
29. Yung AR, Nelson B, Stanford C, Simmons MB, Cosgrave EM, Killackey E, et al. Validation of 'prodromal' criteria to detect individuals at ultra high risks of psychosis: 2 year follow up. Schizophr Res 2008; 105: 10-7.
30. Lemos S, Vanilla O, Fernandez P, Ortega JA, Garcia P, Gutierrez A, et al. Validez predictiva de la escala de sintomas prodromicos (SOPS). [Predictive validity of the Scale of Prodromal Symptoms (SOPS).] Actas Esp Psiquiatr 2006; 34: 216-23.
31. Cannon TD, Cadenhead K, Cornblatt B, Woods SW, Addington J, Walker E, et al. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry 2008; 65: 28-37.
32. Yung AR, Stanford C, Cosgrave E, Killackey E, Phillips L, Nelson B, et al. Testing the ultra high risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people. Schizophr Res 2006; 84: 57-66. (Pubitemid 44255719)
33. Woods SW, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, et al. Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr Bull 2009; 35: 894-908.
34. Ruhrmann S, Schultze-Lutter F, Salokangas RKR, Heinimaa M, Linszen D, Dingermanns P, et al. Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch Gen Psychiatry 2010; 67: 241-51.
35. Lencz T, Smith CW, Auther AM, Correl CU, Cornblatt BA. The assessment of 'prodromal Schizophrenia: unresolved issues and future directions. Schizophr Bull 2003; 29: 717-28. (Pubitemid 38181952)
36. Schultze-Lutter F, Ruhrmann S, Klosterkötter J. Can schizophrenia be predicted phenomenologically? In Evolving Psychosis: Different Stages, Different Treatments (eds JO Johannesen, BV Martidale, J Cullberg): 104-23. Routledge, 2006.
37. Riecher-Rossler A, Pflueger MO, Aston J, Borgwart SJ, Brewer WJ, Gschwandtner U, et al. Efficacy of using cognitive status in predicting psychosis: a 7-year follow up. Biol Psychiatry 2009; 66: 1023-30.
38. Schultze-Lutter F, Ruhrmann S, Berning J, Maier W, Klosterkötter J. Basic symptoms and ultrahigh risk criteria: symptom development in the initial prodromal state. Schizophr Bull 2010; 36: 182-91.
39. Streiner D, Norman G. Health Measurement Scales: A Practical Guide to their Development and Use (3rd edn). Oxford University Press, 2003.
40. First MB, Spitzer RL, Gibbon M, Williams JB. Structured Clinical Interview for DSM-IV Axis I Disorders. New York State Psychiatric Institute, 1995.
41. Heinrichs D, Hanlon T, Carpenter W. The quality of life scales an instrument for rating the schizophrenia deficit syndrome. Schizophr Bull 1984; 10: 388-98.
42. McGorry PD, Goodwin RJ, Stuart GW. The development use and reliability of the brief psychiatric rating scale (nursing modification) an assessment procedure for the nursing team in clinical setting. Compr Psychiatry 1988; 29: 575-87. (Pubitemid 19010792)
43. Andreasen N. Negative symptoms of schizophrenia: definition and reality. Arch Gen Psychiatry 1982; 39: 784-8. (Pubitemid 12090301)
44. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-61.
45. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959; 32: 50-5.
46. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliabilty validity and sensitivity. Br J Psychiatry 1978; 133: 429-35. (Pubitemid 9006756)
47. Hall R. Global assessment of functioning: a modified scale. Psychosom 1995; 36: 267-75.
48. Cannon-Spoor HE, Potkin S0, Wyatt RJ. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull 1982; 8: 471-84.
49. Amundson ME, Hart CA, Holmes TH. Manual for the Schedule of Recent Experience (SRE). University of Washington, 1981.
50. Riecher-Rössler A, Aston J, Ventura J, Merlo M, Borgwardt S, Gschwandtner U. The Basel Screening Instrument for Psychosis (BSIP): development, structure, reliability and validity. Fortschr Neurol Psychiatr 2008; 76: 207-16. (Pubitemid 351985311)
51. Simon AE, Umbricht D. High remission rates from an initial ultra-high risk state for psychosis. Schizophr Res 2010; 116: 168-72.